HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Digging Deeper into Breast Cancer Epigenetics: Insights from Chemical Inhibition of Histone Acetyltransferase TIP60 In Vitro.

Abstract
Breast cancer is often sporadic due to several factors. Among them, the deregulation of epigenetic proteins may be involved. TIP60 or KAT5 is an acetyltransferase that regulates gene transcription through the chromatin structure. This pleiotropic protein acts in several cellular pathways by acetylating proteins. RNA and protein expressions of TIP60 were shown to decrease in some breast cancer subtypes, particularly in triple-negative breast cancer (TNBC), where a low expression of TIP60 was exhibited compared with luminal subtypes. In this study, the inhibition of the residual activity of TIP60 in breast cancer cell lines was investigated by using two chemical inhibitors, TH1834 and NU9056, first on the acetylation of the specific target, lysine 4 of histone 3 (H3K4) by immunoblotting, and second, by chromatin immunoprecipitation (ChIP)-qPCR (-quantitative Polymerase Chain Reaction). Subsequently, significant decreases or a trend toward decrease of H3K4ac in the different chromatin compartments were observed. In addition, the expression of 48 human nuclear receptors was studied with TaqMan Low-Density Array in these breast cancer cell lines treated with TIP60 inhibitors. The statistical analysis allowed us to comprehensively characterize the androgen receptor and NR3C2 receptors in TNBC cell lines after TH1834 or NU9056 treatment. The understanding of the residual activity of TIP60 in the evolution of breast cancer might be a major asset in the fight against this disease, and could allow TIP60 to be used as a biomarker or therapeutic target for breast cancer progression in the future.
AuthorsMouhamed Idrissou, Andre Lebert, Tiphanie Boisnier, Anna Sanchez, Fatma Zohra Houfaf Khoufaf, Frédérique Penault-Llorca, Yves-Jean Bignon, Dominique Bernard-Gallon
JournalOmics : a journal of integrative biology (OMICS) Vol. 24 Issue 10 Pg. 581-591 (10 2020) ISSN: 1557-8100 [Electronic] United States
PMID32960142 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Histone Deacetylase Inhibitors
  • Histones
  • KAT5 protein, human
  • Lysine Acetyltransferase 5
Topics
  • Binding Sites
  • Breast Neoplasms (drug therapy, genetics, metabolism, pathology)
  • Cell Line, Tumor
  • Chromatin Immunoprecipitation Sequencing
  • Epigenesis, Genetic
  • Epigenomics (methods)
  • Female
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Histone Deacetylase Inhibitors (pharmacology)
  • Histones (metabolism)
  • Humans
  • Lysine Acetyltransferase 5 (antagonists & inhibitors, metabolism)
  • Protein Binding

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: